Skip to main content
STRATEC SE logo

STRATEC SE — Investor Relations & Filings

Ticker · SBS ISIN · DE000STRA555 LEI · 529900ZZJWANAFSPGV30 F Manufacturing
Open in API
Filings indexed 828 across all filing types
Latest filing 2011-03-08 Annual Report
Country DE Germany
Listing F SBS

About STRATEC SE

https://www.stratec.com/home

STRATEC SE is a global partner specializing in the design and manufacturing of fully automated solutions for OEM partners in the clinical diagnostics and life sciences industries. The company provides a comprehensive, integrated portfolio covering the entire value chain, from development and design to production and quality assurance. Its core offerings include fully automated analyzer systems (instrumentation), custom software and digital IoT solutions, and smart polymer-based consumables. Leveraging decades of experience and a broad technology base, STRATEC delivers tailored, high-quality systems that meet stringent regulatory standards, enabling its partners to bring advanced diagnostic and life science products to market.

Recent filings

Filing Released Lang Actions
Annual Report 2010
Annual Report Classification · 1% confidence The document contains a comprehensive review of the 2010 financial year, including a letter to shareholders, the Report of the Supervisory Board, corporate governance details, and references to consolidated financial statements and management reports. It is a full-length annual report document for STRATEC Biomedical Systems AG, covering the fiscal year 2010. FY 2010
2011-03-08 German
Report Publication Announcement 2011
Report Publication Announcement Classification · 1% confidence The document is very short (1579 characters) and explicitly states that it is an 'Announcement according to articles 37v, 37w, 37x ff. WpHG' regarding the disclosure of financial statements. It specifies the 'Report: Annual financial report of the group' and provides the 'Date of disclosure / German: March 08, 2011' and links. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report will be published or is attached classifies as a Report Publication Announcement (RPA), not the full report itself (which would be 10-K).
2011-02-28 English
STRATEC proposes increased dividend of Euro 0.50 per share
Notice of Dividend Amount Classification · 1% confidence The document is a corporate news release dated February 28, 2011, announcing that STRATEC's management will propose an increased dividend of Euro 0.50 per share for shareholder approval at the upcoming Annual General Meeting (AGM) on April 14, 2011. This announcement directly concerns the dividend amount and payment details, which aligns perfectly with the definition for 'Notice of Dividend Amount' (DIV). Although it mentions the AGM, the primary focus is the dividend proposal, not AGM materials (AGM-R) or proxy solicitation (PSI). It is not a full report (10-K, IR) and is more specific than a general regulatory filing (RNS).
2011-02-28 English
Wolfgang Wehmeyer appointed to Supervisory Board of STRATEC Biomedical Systems AG
Board/Management Information Classification · 1% confidence The document is a corporate news release dated February 8, 2011, announcing the appointment of Wolfgang Wehmeyer to the Supervisory Board of STRATEC Biomedical Systems AG. This type of announcement concerns changes in the company's governing body (Board of Directors/Supervisory Board). According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' Although the appointment is expected to be confirmed at the AGM, the immediate news item is the personnel change itself, making MANG the most appropriate classification over AGM-R or a general regulatory filing.
2011-02-08 English
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states in the header that it is a 'Voting Rights Announcement' and details changes in the share of voting rights held by various entities (FIL Limited, FIL Investment Management Limited, etc.) in STRATEC Biomedical Systems AG, referencing specific sections of the German Securities Trading Act (WpHG). This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2011-01-03 English
STRATEC announces agreement with Abbott Diagnostics
M&A Activity Classification · 1% confidence The document is a short news release dated December 14, 2010, announcing that STRATEC has signed an agreement with Abbott Diagnostics for co-development and supply of an analyzer system. It is not a comprehensive financial report (like 10-K or IR), nor is it a specific announcement like a dividend (DIV) or director dealing (DIRS). It is a general corporate announcement regarding a business contract/partnership. Since it doesn't fit the specific categories like M&A (TAR), Capital (CAP), or Earnings (ER), and it is a formal announcement disseminated via a service (DGAP), the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate news that doesn't fit elsewhere, especially when it's a material business update that isn't a standard financial filing.
2010-12-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.